These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1592697)

  • 1. Permeability of the outer membrane of Moraxella catarrhalis for beta-lactam antibiotics.
    Gotoh N; Tanaka S; Nishino T
    J Antimicrob Chemother; 1992 Mar; 29(3):279-85. PubMed ID: 1592697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreases of the susceptibility to low molecular weight beta-lactam antibiotics in imipenem-resistant Pseudomonas aeruginosa mutants: role of outer membrane protein D2 in their diffusion.
    Gotoh N; Nishino T
    J Antimicrob Chemother; 1990 Feb; 25(2):191-8. PubMed ID: 2109748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Serotype distribution and drug resistance of
    Tian HL; Shi W; Zhou HF; Yuan L; Yao KH; Rexiati D; Xu AM
    Zhonghua Er Ke Za Zhi; 2018 Apr; 56(4):279-283. PubMed ID: 29614568
    [No Abstract]   [Full Text] [Related]  

  • 4. Antimicrobial susceptibility to β-lactam antibiotics and production of BRO β-lactamase in clinical isolates of Moraxella catarrhalis from a Japanese hospital.
    Yamada K; Arai K; Saito R
    J Microbiol Immunol Infect; 2017 Jun; 50(3):386-389. PubMed ID: 28057435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffusion of beta-lactam antibiotics through oligomeric or monomeric porin channels of some gram-negative bacteria.
    Nitzan Y; Deutsch EB; Pechatnikov I
    Curr Microbiol; 2002 Dec; 45(6):446-55. PubMed ID: 12402087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. beta-Lactam resistance and beta-lactamase isoforms of Moraxella catarrhalis isolates in Taiwan.
    Fung CP; Lee SC; Liu PY; Jang TN; Wong FD; Kuo BI; Liu CY; Liu YC
    J Formos Med Assoc; 1998 Jul; 97(7):453-7. PubMed ID: 9700241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of oral beta-lactam antimicrobial agents versus respiratory tract isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the era of antibiotic resistance.
    Doern GV
    Otolaryngol Head Neck Surg; 2002 Dec; 127(6 Suppl):S17-23. PubMed ID: 12511856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion of beta-lactam antibiotics into proteoliposomes reconstituted with outer membranes of isogenic imipenem-susceptible and -resistant strains of Enterobacter cloacae.
    Lee EH; Collatz E; Trias J; Gutmann L
    J Gen Microbiol; 1992 Nov; 138(11):2347-51. PubMed ID: 1336033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial susceptibility and beta-lactamase production of Moraxella catarrhalis isolates in Taiwan.
    Fung CP; Jang TN; Liu CY; Lau YJ; Liu YC; Chuang YC; Lee N
    J Formos Med Assoc; 1995 Sep; 94(9):548-54. PubMed ID: 8696169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of cell-bound papain-soluble beta-lactamases in BRO-1 and BRO-2 producing strains of Moraxella (Branhamella) catarrhalis and Moraxella nonliquefaciens.
    Eliasson I; Kamme C; Vang M; Waley SG
    Eur J Clin Microbiol Infect Dis; 1992 Apr; 11(4):313-21. PubMed ID: 1396750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Supersusceptibility to hydrophobic antimicrobial agents and cell surface hydrophobicity in Branhamella catarrhalis.
    Gotoh N; Tanaka S; Nishino T
    FEMS Microbiol Lett; 1989 May; 50(1-2):211-3. PubMed ID: 2500380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Size of diffusion pore of Alcaligenes faecalis.
    Ishii J; Nakae T
    Antimicrob Agents Chemother; 1988 Mar; 32(3):378-84. PubMed ID: 2835003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial susceptibility and beta-lactamase characterization of Branhamella catarrhalis isolates from 1983/1984 and 1988.
    Christensen JJ; Keiding J; Bruun B
    APMIS; 1990 Nov; 98(11):1039-44. PubMed ID: 2123390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffusion of aminoglycoside antibiotics across the outer membrane of Escherichia coli.
    Nakae R; Nakae T
    Antimicrob Agents Chemother; 1982 Oct; 22(4):554-9. PubMed ID: 6758685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro investigation of the indirect pathogenicity of beta-lactamase-producing microorganisms in the nasopharyngeal microflora.
    Kaieda S; Yano H; Okitsu N; Hosaka Y; Okamoto R; Inoue M; Takahashi H
    Int J Pediatr Otorhinolaryngol; 2005 Apr; 69(4):479-85. PubMed ID: 15763284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of BRO enzymes and beta-lactamase transfer of Moraxella (Branhamella) catarrhalis isolated in Japan.
    Ikeda F; Yokota Y; Mine Y; Yamada T
    Chemotherapy; 1993; 39(2):88-95. PubMed ID: 8458251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The barrier function of the outer membrane of Pseudomonas maltophilia in the diffusion of saccharides and beta-lactam antibiotics.
    Yamazaki E; Ishii J; Sato K; Nakae T
    FEMS Microbiol Lett; 1989 Jul; 51(1):85-8. PubMed ID: 2676712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The frequency of BRO β-lactamase and its relationship to antimicrobial susceptibility and serum resistance in Moraxella catarrhalis.
    Saito R; Nonaka S; Fujinami Y; Matsuoka S; Nakajima S; Nishiyama H; Okamura N
    J Infect Chemother; 2014 Jan; 20(1):6-8. PubMed ID: 24462416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of susceptibility patterns and BRO beta-lactamase types among clinical isolates of Moraxella catarrhalis.
    Esel D; Ay-Altintop Y; Yagmur G; Gokahmetoglu S; Sumerkan B
    Clin Microbiol Infect; 2007 Oct; 13(10):1023-5. PubMed ID: 17608812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations affecting the resistance of Escherichia coli K-12 to beta-lactam antibiotics.
    Hrebenda J; Heleszko H
    J Antimicrob Chemother; 1985 Aug; 16(2):149-56. PubMed ID: 3905746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.